Saving Lives with Compassion: Overdose Response Training with RiVive庐
This webinar will present findings from the 2025 RiVive Community Engagement Report and best practices in compassionate overdose response™, with a focus on the community use of RiVive naloxone nasal spray 3 mg. A panel of expert speakers will present their protocols for effective overdose intervention, guidance on the training of others, and strategies for integrating trauma-informed approaches into post-overdose care.
The webinar will cover why compassionate dosing is important, how to integrate this concept into trainings for community members, and communication strategies for teaching titration, rescue breathing, and overdose prevention.
Designed for program teams, medical professionals, and harm reduction leaders, anyone who attends will leave with research and experience-backed methods for improving outcomes in opioid overdose emergencies. A recording of this webinar will be available after this session, with a link to the 2025 report.
Learning Objectives:
- Learn how to describe why compassionate dosing is important.
- Apply evidence-based strategies for compassionate, trauma-informed intervention during overdose emergencies.
- Integrate stigma-reducing practices into community response frameworks to enhance support for individuals affected by opioid use.
Speakers:
- Dr. Michael Hufford, Co-Founder, CEO, Harm Reduction Therapeutics
- Van Asher, Harm Reduction Consultant, Harm Reduction Therapeutics
